Shenzhen New Industries Biomedical Engineering Co., Ltd. Stock
Equities
300832
CNE100003T39
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
75.72 CNY | -0.36% | +2.81% | -3.17% |
Sales 2024 * | 4.92B 679M | Sales 2025 * | 6.17B 853M | Capitalization | 59.49B 8.22B |
---|---|---|---|---|---|
Net income 2024 * | 2.06B 285M | Net income 2025 * | 2.6B 360M | EV / Sales 2024 * | 11.7 x |
Net cash position 2024 * | 2.04B 282M | Net cash position 2025 * | 3.09B 427M | EV / Sales 2025 * | 9.14 x |
P/E ratio 2024 * |
28.9
x | P/E ratio 2025 * |
22.8
x | Employees | 2,627 |
Yield 2024 * |
1.65% | Yield 2025 * |
2.06% | Free-Float | 39.42% |
1 day | -0.36% | ||
1 week | +2.81% | ||
1 month | +7.10% | ||
3 months | -6.09% | ||
6 months | +4.28% | ||
Current year | -3.17% |
Managers | Title | Age | Since |
---|---|---|---|
Wei Rao
CEO | Chief Executive Officer | 60 | 12-08-16 |
Chen Liu Ding
DFI | Director of Finance/CFO | 49 | 04-09-30 |
Jie Ma
BRD | Director/Board Member | 31 | 16-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Qing Wei Zhang
BRD | Director/Board Member | 49 | 12-07-31 |
Wei Rao
CEO | Chief Executive Officer | 60 | 12-08-16 |
Dai Na Wang
BRD | Director/Board Member | 61 | 18-09-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.68% | 2 M€ | -14.14% | ||
0.67% | 2 M€ | -18.79% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 75.72 | -0.36% | 2,454,288 |
24-05-30 | 75.99 | +0.30% | 1,367,060 |
24-05-29 | 75.76 | +0.99% | 1,175,364 |
24-05-28 | 75.02 | -1.04% | 1,770,847 |
24-05-27 | 75.81 | +2.93% | 2,014,538 |
End-of-day quote Shenzhen S.E., May 30, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.17% | 8.22B | |
-3.43% | 12.45B | |
+6.11% | 5.72B | |
+31.98% | 5.67B | |
-10.03% | 4.11B | |
-59.94% | 2.68B | |
+11.23% | 2.68B | |
-5.14% | 2.37B | |
+18.91% | 2.06B | |
-7.56% | 1.8B |
- Stock Market
- Equities
- 300832 Stock